BFA
AGIO icon

BlackRock Fund Advisors’s Agios Pharmaceuticals AGIO Stock Holding History

BlackRock Fund Advisors’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$38.3M Buy
917,140
+106,902
+13% +$5.61M 0.01% 1837
2016
Q3 		$42.8M Buy
810,238
+45,653
+6% +$1.99M 0.01% 1688
2016
Q2 		$32M Buy
764,585
+34,388
+5% +$1.7M 0.01% 1766
2016
Q1 		$29.6M Buy
730,197
+46,287
+7% +$1.98M 0.01% 1757
2015
Q4 		$44.4M Sell
683,910
-82,873
-11% -$5.44M 0.01% 1558
2015
Q3 		$54.1M Buy
766,783
+81,037
+12% +$7.92M 0.01% 1373
2015
Q2 		$76.2M Sell
685,746
-155,473
-18% -$16.7M 0.02% 1224
2015
Q1 		$79.3M Buy
841,219
+55,997
+7% +$6.27M 0.02% 1188
2014
Q4 		$88M Buy
785,222
+70,604
+10% +$6.3M 0.02% 1044
2014
Q3 		$43.8M Buy
714,618
+10,968
+2% +$473K 0.01% 1436
2014
Q2 		$32.2M Buy
703,650
+153,524
+28% +$6.26M 0.01% 1701
2014
Q1 		$21.5M Buy
550,126
+21,550
+4% +$721K 0.01% 1961
2013
Q4 		$12.7M Buy
528,576
+352,966
+201% +$8.04M ﹤0.01% 2240
2013
Q3 		$4.91M Buy
+175,610
New +$4.85M ﹤0.01% 2822

Other funds holding AGIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BlackRock Fund Advisors's AGIO Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Agios Pharmaceuticals (AGIO) stake by 13% in Q4 2016, buying an estimated $5.61M and bringing the position to 917,140 shares worth $38.3M. The position accounts for 0.01% of the portfolio, ranked #1837.

BlackRock Fund Advisors first reported a position in AGIO in Q3 2013 and has held it in 14 quarters since. The position peaked at $88M in Q4 2014. 161 funds tracked by Wall St. Rank hold AGIO as of Q4 2016.

  • BlackRock Fund Advisors held 917,140 shares of Agios Pharmaceuticals worth $38.3M as of Q4 2016.
  • BlackRock Fund Advisors bought 106,902 Agios Pharmaceuticals shares in Q4 2016, an estimated $5.61M.
  • Agios Pharmaceuticals made up 0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #1837 holding.
  • BlackRock Fund Advisors first reported a position in Agios Pharmaceuticals in Q3 2013 and has held it in 14 quarters since.
  • BlackRock Fund Advisors's Agios Pharmaceuticals position peaked at $88M in Q4 2014.
  • 161 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.